Breathe Biologics
Oceanside, United States (US) · Health and Medical
Do your work at Breathe Biologics?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
#regenerative medicine
#biotech
#pulmonology
#ards
#copd
#lung failure
#sepsis
#pulmonary hypertension
#asthma
#emphysema
Overview
Breathe Biologics is a US-based regenerative medicine company specializing in innovative stem cell therapies for severe lung diseases, including ARDS, COPD, and pulmonary hypertension.
We are dedicated to improving patient outcomes through the development of ‘JadiCell™,’ our patented umbilical cord-derived mesenchymal stem cell, a truly scalable biologic therapy.
Breathe Biologics leverages a multidisciplinary team of experts in cell biology, pulmonology, and clinical development to advance our pipeline of therapies, currently focused on securing FDA approval for JadiCell in ARDS and COPD. Our commitment to rigorous clinical research and a patient-centric approach positions us as a leader in the field of regenerative medicine.
Founded in 2026, Breathe Biologics has already achieved significant milestones, including filing pivotal Phase 3 clinical trial applications for JadiCell in ARDS and initiating clinical trials for COPD. We are actively pursuing ‘Right to Try’ opportunities to provide access to our therapies for patients in need.
We are dedicated to improving patient outcomes through the development of ‘JadiCell™,’ our patented umbilical cord-derived mesenchymal stem cell, a truly scalable biologic therapy.
Breathe Biologics leverages a multidisciplinary team of experts in cell biology, pulmonology, and clinical development to advance our pipeline of therapies, currently focused on securing FDA approval for JadiCell in ARDS and COPD. Our commitment to rigorous clinical research and a patient-centric approach positions us as a leader in the field of regenerative medicine.
Founded in 2026, Breathe Biologics has already achieved significant milestones, including filing pivotal Phase 3 clinical trial applications for JadiCell in ARDS and initiating clinical trials for COPD. We are actively pursuing ‘Right to Try’ opportunities to provide access to our therapies for patients in need.
Contact Details
+1407-217-3327
info@breathebiologics.com
Oceanside, United States (US), 4093 Oceanside Blvd.
+1
Founded
2026
Company Type
Private Limited Company
Employees
2-10
Categories
Keywords
#regenerative medicine
#biotech
#pulmonology
#ards
#copd
#lung failure
#sepsis
#pulmonary hypertension
#asthma
#emphysema
Companies teams usually look at after Breathe Biologics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.